4.5 Article

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Human interferon-λ3 is a potent member of the type III interferon family

C. Dellgren et al.

GENES AND IMMUNITY (2009)

Article Biochemistry & Molecular Biology

Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family

Hans Henrik Gad et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Biotechnology & Applied Microbiology

Interferon-beta treatment for relapsing multiple sclerosis

Bianca Weinstock-Guttman et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2008)

Review Oncology

Next generation of immunotherapy for melanoma

John M. Kirkwood et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Review Pharmacology & Pharmacy

IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases

Robert Sabat et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2007)

Article Genetics & Heredity

Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response

W. J. Jordan et al.

GENES AND IMMUNITY (2007)

Article Biochemistry & Molecular Biology

Differential receptor subunit affinities of Type I interferons govern differential signal activation

Eva Jaks et al.

JOURNAL OF MOLECULAR BIOLOGY (2007)

Article Gastroenterology & Hepatology

IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet

Juergen Siebler et al.

GASTROENTEROLOGY (2007)

Article Genetics & Heredity

Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda 1/IL-29)

W. J. Jordan et al.

GENES AND IMMUNITY (2007)

Article Biochemistry & Molecular Biology

IL-28 and IL-29: Newcomers to the interferon family

Gilles Uze et al.

BIOCHIMIE (2007)

Review Biochemistry & Molecular Biology

Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells

Kerstin Wolk et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2006)

Article Biochemistry & Molecular Biology

Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity

Michal Slutzki et al.

JOURNAL OF MOLECULAR BIOLOGY (2006)

Article Immunology

Antitumor activity of IFN-ℷ in murine tumor models

Atsuko Sato et al.

JOURNAL OF IMMUNOLOGY (2006)

Article Gastroenterology & Hepatology

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression

S Brand et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)

Article Biochemistry & Molecular Biology

Biological activity of interleukins-28 and-29: Comparison with type I interferons

A Meager et al.

CYTOKINE (2005)

Article Virology

Lambda interferon inhibits hepatitis B and C virus replication

MD Robek et al.

JOURNAL OF VIROLOGY (2005)

Article Immunology

IL-22 increases the innate immunity of tissues

K Wolk et al.

IMMUNITY (2004)

Article Biochemistry & Molecular Biology

Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers

P Lamken et al.

JOURNAL OF MOLECULAR BIOLOGY (2004)

Review Immunology

Interleukin-10 and related cytokines and receptors

S Pestka et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)

Article Biochemistry & Molecular Biology

Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance

K Wolk et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Immunology

IL-28, IL-29 and their class II cytokine receptor IL-28R

P Sheppard et al.

NATURE IMMUNOLOGY (2003)

Article Gastroenterology & Hepatology

Management issues in chronic viral hepatitis: Hepatitis C

W Sievert

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)